<H1>Chapter DOI: 10.1186/s13148-016-0232-3<br/>Cited-By Count: 0</H1><table border="1" width="30%"><tr><td>Total References</td><td>34</td></tr><tr><td>Springer references</td><td>2</td></tr><tr><td>Non Springer references</td><td>32</td></tr><tr><td>BibStructured Count</td><td width="10%">34</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>30</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>0</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>0</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>0</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Arbyn M, Castelisagu&#233; X, de Sanjos&#233; S, Bruni L, Saralya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22:2675&#8211;86.</td><td><a href=http://dx.doi.org/10.1093/annonc/mdr015>10.1093/annonc/mdr015</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893&#8211;917.</td><td><a href=http://dx.doi.org/10.1002/ijc.25516>10.1002/ijc.25516</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Cannistra SA, Niloff JM. Cancer of the uterine cervix. N Engl J Med. 1996;334:1030&#8211;8.</td><td><a href=http://dx.doi.org/10.1056/NEJM199604183341606>10.1056/NEJM199604183341606</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol. 1995;141:680&#8211;9.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Koliopoulos G, Arbyn M, Martin-Hirsch P, Kyrgiou M, Prendiville W, Paraskevaidis E. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol. 2007;104:232&#8211;46.</td><td><a href=http://dx.doi.org/10.1016/j.ygyno.2006.08.053>10.1016/j.ygyno.2006.08.053</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>American College of Obstetricians and Gynecologists. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 61, April 2005. Human papillomavirus. Obstet Gynecol. 2005;105:905&#8211;18.</td><td><a href=http://dx.doi.org/10.1097/00006250-200504000-00056>10.1097/00006250-200504000-00056</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Li J, Kang LN, Qiao YL. Review of the cervical cancer disease burden in mainland China. Asian Pac J Cancer Prev. 2011;12:1149&#8211;53.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Zhao P, Dai M, Chen W, Li N. Cancer trends in China. Jpn J Clin Oncol. 2010;40:281&#8211;5.</td><td><a href=http://dx.doi.org/10.1093/jjco/hyp187>10.1093/jjco/hyp187</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Baay MF, Weyler J, Vermorken JB. The value of human papillomavirus detection in primary cervical cancer screening. Eur J Gynaecol Oncol. 2004;25:665&#8211;9.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Molijn A, Kleter B, Quint W, van Doorn LJ. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol. 2005;32:S43&#8211;51.</td><td><a href=http://dx.doi.org/10.1016/j.jcv.2004.12.004>10.1016/j.jcv.2004.12.004</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005;32:S16&#8211;24.</td><td><a href=http://dx.doi.org/10.1016/j.jcv.2004.12.008>10.1016/j.jcv.2004.12.008</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357:1579&#8211;88.</td><td><a href=http://dx.doi.org/10.1056/NEJMoa071430>10.1056/NEJMoa071430</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Wang R, Guo XL, Wisman GB, Schuuring E, Wang WF, Zeng ZY, et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. BMC Infect Dis. 2015;15:257.</td><td><a href=http://dx.doi.org/10.1186/s12879-015-0998-5>10.1186/s12879-015-0998-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137:516&#8211;42.</td><td><a href=http://dx.doi.org/10.1309/AJCPTGD94EVRSJCG>10.1309/AJCPTGD94EVRSJCG</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Wentzensen N, Fetterman B, Castle PE, Schiffman M, Wood SN, Stiemerling E, et al. p16/Ki-67 dual stain cytology for detection of cervical precancer in HPV-positive women. J Natl Cancer Inst. 2015;107:djv257.</td><td><a href=http://dx.doi.org/10.1093/jnci/djv257>10.1093/jnci/djv257</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358:1148&#8211;59.</td><td><a href=http://dx.doi.org/10.1056/NEJMra072067>10.1056/NEJMra072067</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Steenbergen RD, Snijders PJ, Heideman DA, Meijer CJ. Clinical implications of (epi) genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer. 2014;14:395&#8211;405.</td><td><a href=http://dx.doi.org/10.1038/nrc3728>10.1038/nrc3728</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Jones A, Lechner M, Fourkala EO, Kristeleit R, Widschwendter M. Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women&#8217;s cancers. Epigenomics. 2010;2:9&#8211;38.</td><td><a href=http://dx.doi.org/10.2217/epi.09.47>10.2217/epi.09.47</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Liou YL, Zhang Y, Liu Y, Cao L, Qin CZ, Zhang TL, et al. Comparison of HPV genotyping and methylated ZNF582 as triage for women with equivocal liquid-based cytology results. Clin Epigenetics. 2015;7:50.</td><td><a href=http://dx.doi.org/10.1186/s13148-015-0084-2>10.1186/s13148-015-0084-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Chang CC, Huang RL, Wang HC, Liao YP, Yu MH, Lai HC. High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma. Int J Gynecol Cancer. 2014;24:201&#8211;9.</td><td><a href=http://dx.doi.org/10.1097/IGC.0000000000000054>10.1097/IGC.0000000000000054</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Kan YY, Liou YL, Wang HJ, Chen CY, Sung LC, Chang CF, et al. PAX1 methylation as a potential biomarker for cervical cancer screening. Int J Gynecol Cancer. 2014;24:928&#8211;34.</td><td><a href=http://dx.doi.org/10.1097/IGC.0000000000000155>10.1097/IGC.0000000000000155</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Lai HH, Qu YC, Chen TC, Huang HJ, Cheng YM, Chen CH, et al. PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese gynecologic oncology group (TGOG) study. Cancer Med. 2014;3:1062&#8211;74.</td><td><a href=http://dx.doi.org/10.1002/cam4.253>10.1002/cam4.253</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Chao TK, Ke FY, Liao YP, Wang HC, Yu CP, Lai HC. Triage of cervical cytological diagnoses of atypical squamous cells by DNA methylation of paired boxed gene 1 (PAX1). Diagn Cytopathol. 2011;41:41&#8211;6.</td><td><a href=http://dx.doi.org/10.1002/dc.21758>10.1002/dc.21758</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Lin H, Chen TC, Chang TC, Cheng YM, Chen CH, Chu TY, et al. Methylated ZNF582 gene as a marker for triage of women with Pap smear reporting low grade squamous intraepithelial lesions&#8212;a Taiwanese gynecologic oncology group (TGOG) study. Gynecol Oncol. 2014;135:64&#8211;8.</td><td><a href=http://dx.doi.org/10.1016/j.ygyno.2014.08.012>10.1016/j.ygyno.2014.08.012</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Lai HC, Lin YW, Huang RL, Chung MT, Wang HC, Liao YP, et al. Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse. Cancer. 2010;116:4266&#8211;74.</td><td><a href=http://dx.doi.org/10.1002/cncr.25252>10.1002/cncr.25252</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Huang RL, Chang CC, Su PH, Chen YC, Liao YP, Wang HC, et al. Methylomic analysis identifies frequent DNA methylation of zinc finger protein 582 (ZNF582) in cervical neoplasms. PLoS One. 2012;7:e41060.</td><td><a href=http://dx.doi.org/10.1371/journal.pone.0041060>10.1371/journal.pone.0041060</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Guerrero-Preston R, Michailidi C, Marchionni L, Pickering CR, Frederick MJ, Myers JM, et al. Key tumor suppressor genes inactivated by &#8220;greater promoter&#8221; methylation and somatic mutations in head and neck cancer. Epigenetics. 2014;9:1031&#8211;46.</td><td><a href=http://dx.doi.org/10.4161/epi.29025>10.4161/epi.29025</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Bhat S, Kabekkodu SP, Noronha A, Satyamoorthy K. Biological implications and therapeutic significance and DNA methylation regulated genes in cervical cancer. Biochimie. 2016;121:298&#8211;311.</td><td><a href=http://dx.doi.org/10.1016/j.biochi.2015.12.018>10.1016/j.biochi.2015.12.018</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Solomon D, Davey D, Kurman R, Moriarty A, O&#8217;Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114&#8211;9.</td><td><a href=http://dx.doi.org/10.1001/jama.287.16.2114>10.1001/jama.287.16.2114</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Ngan HY, Garland SM, Bhatla N, Pagliusi SR, Chan KK, Cheung AN, et al. Asia Oceania guidelines for the implementation of programs for cervical cancer prevention and control. J Cancer Epidemiol. 2011;2011:794861.</td><td><a href=http://dx.doi.org/10.1155/2011/794861>10.1155/2011/794861</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Lin H, Moh JS, Ou YC, Shen SY, Tsai YM, ChangChien CC, et al. A simple method for the detection and genotyping of high-risk human papillomavirus using seminested polymerase chain reaction and reverse hybridization. Gynecol Oncol. 2005;96:84&#8211;91.</td><td><a href=http://dx.doi.org/10.1016/j.ygyno.2004.09.043>10.1016/j.ygyno.2004.09.043</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370:1287&#8211;97.</td><td><a href=http://dx.doi.org/10.1056/NEJMoa1311194>10.1056/NEJMoa1311194</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Nikolaidis C, Nena E, Panagopoulou M, Balgkouranidou I, Karaglani M, Chatzaki E, et al. PAX1 methylation as an auxiliary biomarker for cervical cancer screening: a meta-analysis. Cancer Epidemiol. 2015;39:682&#8211;6.</td><td><a href=http://dx.doi.org/10.1016/j.canep.2015.07.008>10.1016/j.canep.2015.07.008</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Tu Z, Xu A, Bian M, et al. Opportunistic screening for cervical cancer in 12 hospitals in China. J Practical Obstet Gynaecol. 2009;5:278&#8211;81.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></table>